0.9(top 50%)
impact factor
219(top 50%)
papers
4.2K(top 20%)
citations
35(top 20%)
h-index
0.9(top 50%)
extended IF
268
all documents
4.3K
doc citations
52(top 20%)
g-index

Top Articles

#TitleJournalYearCitations
1The Nrf2-ARE Pathway: A Valuable Therapeutic Target for the Treatment of Neurodegenerative DiseasesRecent Patents on CNS Drug Discovery2012196
2The Injured Cochlea as a Target for Inflammatory Processes, Initiation of Cell Death Pathways and Application of Related Otoprotective StrategiesRecent Patents on CNS Drug Discovery2010120
3Exosome-based strategies for Diagnosis and TherapyRecent Patents on CNS Drug Discovery201597
4Incretin Analogues that have been Developed to Treat Type 2 Diabetes Hold Promise as a Novel Treatment Strategy for Alzheimers DiseaseRecent Patents on CNS Drug Discovery201094
5Editorial :Recent Patents on CNS Drug Discovery201493
6Modulation of Sirtuins: New Targets for AntiageingRecent Patents on CNS Drug Discovery200881
7Blocking Striatal Adenosine A2A Receptors: A New Strategy for Basal Ganglia DisordersRecent Patents on CNS Drug Discovery200779
8Galanthamine, a Natural Product for the Treatment of Alzheimers DiseaseRecent Patents on CNS Drug Discovery200673
9Contemporary Anticholinesterase Pharmaceuticals of Natural Origin and Their Synthetic Analogues for the Treatment of Alzheimers DiseaseRecent Patents on CNS Drug Discovery200969
10Neuropeptide Y as an Endogenous Antiepileptic, Neuroprotective and Pro-Neurogenic PeptideRecent Patents on CNS Drug Discovery200665
11Cannabinoid-related Agents in the Treatment of Anxiety Disorders: Current Knowledge and Future PerspectivesRecent Patents on CNS Drug Discovery201265
12Cannabinoids: Novel Medicines for the Treatment of Huntingtons DiseaseRecent Patents on CNS Drug Discovery201264
13Blockers of Voltage-Gated Sodium Channels for the Treatment of Central Nervous System DiseasesRecent Patents on CNS Drug Discovery200763
14Inflammation: Beneficial or Detrimental After Spinal Cord Injury?Recent Patents on CNS Drug Discovery200862
15Curcuminoids in Neurodegenerative DiseasesRecent Patents on CNS Drug Discovery201259
16Patented In Vitro Blood-Brain Barrier Models in CNS Drug DiscoveryRecent Patents on CNS Drug Discovery201158
17Advances in Oncolytic Virus Therapy for GliomaRecent Patents on CNS Drug Discovery200957
18Therapeutic Potential of Cannabinoids in SchizophreniaRecent Patents on CNS Drug Discovery201457
19Recent Patents on Novel P2X7 Receptor Antagonists and their Potential for Reducing Central Nervous System InflammationRecent Patents on CNS Drug Discovery201056
20BACE Inhibitors as Potential Drugs for the Treatment of Alzheimers Disease: Focus on BioactivityRecent Patents on CNS Drug Discovery201154
21Recent Patents in CNS Drug Discovery: The Management of Inflammation in the Central Nervous SystemRecent Patents on CNS Drug Discovery200954
22TRPV1 Antagonists as a Potential Treatment for HyperalgesiaRecent Patents on CNS Drug Discovery200652
23Analgesic and Antineuropathic Drugs Acting Through Central Cholinergic MechanismsRecent Patents on CNS Drug Discovery201152
24Tianeptine: A Novel Atypical Antidepressant that May Provide New Insights into the Biomolecular Basis of DepressionRecent Patents on CNS Drug Discovery200650
25Lipid-Based Nanocarriers for CNS-Targeted Drug DeliveryRecent Patents on CNS Drug Discovery201250
26Rho-ROCK Inhibitors for the Treatment of CNS InjuryRecent Patents on CNS Drug Discovery200744
27Potassium Channel Blockers and Openers as CNS Neurologic Therapeutic AgentsRecent Patents on CNS Drug Discovery200744
28The Seek of Neuroprotection: Introducing CannabinoidsRecent Patents on CNS Drug Discovery200742
29Inhibitors of the Endocannabinoid-Degrading Enzymes, or how to Increase Endocannabinoids Activity by Preventing their HydrolysisRecent Patents on CNS Drug Discovery201242
30Vasopressin Antagonists as Anxiolytics and Antidepressants: Recent DevelopmentsRecent Patents on CNS Drug Discovery200841
31Therapeutic Potential of Adult Neural Stem CellsRecent Patents on CNS Drug Discovery200640
32Muscarinic Acetylcholine Receptors: New Potential Therapeutic Targets in Antinociception and in Cancer TherapyRecent Patents on CNS Drug Discovery200840
33Advances in the Discovery of Novel Positive Allosteric Modulators of the α7 Nicotinic Acetylcholine ReceptorRecent Patents on CNS Drug Discovery200739
34Modulation of the TRPV1 Channel: Current Clinical Trials and Recent Patents with Focus on Neurological ConditionsRecent Patents on CNS Drug Discovery201439
35The Role of Melatonin in the Immuno-Neuro-Psychology of Mental DisordersRecent Patents on CNS Drug Discovery200936
36Voltage-Gated Sodium Channel Blockers as ImmunomodulatorsRecent Patents on CNS Drug Discovery200635
37Glutamatergic Dysfunction-Newer Targets for Anti-Obsessional DrugsRecent Patents on CNS Drug Discovery200735
38Naturally Occurring and Related Synthetic Cannabinoids and their Potential Therapeutic ApplicationsRecent Patents on CNS Drug Discovery200935
39Selective Dopamine D3 Receptor Antagonists: A Review 2001-2005Recent Patents on CNS Drug Discovery200633
40Glycine Transporter Inhibitors as Therapeutic Agents for SchizophreniaRecent Patents on CNS Drug Discovery200632
41Non-Monoamine-Based Approach for the Treatment of Depression and Anxiety DisordersRecent Patents on CNS Drug Discovery200632
42An Update on GABA Analogs for CNS Drug DiscoveryRecent Patents on CNS Drug Discovery200632
43New Pharmacological Approaches to the Cholinergic System: An Overview on Muscarinic Receptor Ligands and Cholinesterase InhibitorsRecent Patents on CNS Drug Discovery201332
44Insulin-Like Growth Factor-1 and its Derivatives: Potential Pharmaceutical Application for Ischemic Brain InjuryRecent Patents on CNS Drug Discovery200831
45Humanin; A Defender Against Alzheimers Disease?Recent Patents on CNS Drug Discovery200931
46Therapeutic Treatment of Alzheimers Disease Using Metal Complexing AgentsRecent Patents on CNS Drug Discovery200730
47Pharmacology and Toxicology of Cannabis Derivatives and Endocannabinoid AgonistsRecent Patents on CNS Drug Discovery201030
48The Role of Stem Cell Factor and Granulocyte-Colony Stimulating Factor in Treatment of StrokeRecent Patents on CNS Drug Discovery201329
49Pharmacological Approaches to Targeting Muscarinic Acetylcholine ReceptorsRecent Patents on CNS Drug Discovery201429
50Protective Substances Against Zinc-Induced Neuronal Death after Ischemia:Carnosine as a Target for Drug of Vascular Type of DementiaRecent Patents on CNS Drug Discovery200728